Bromelain: Pineapple Enzyme Science & Human Research

This page is part of the AMLApure Ingredient Science Library. It is intended for holistic, integrative, and nutrition-focused healthcare professionals and scientifically interested consumers. Content is educational and does not constitute medical advice.

Bromelain: Pineapple Enzyme Science & Human Research

What Is Bromelain?

Bromelain is not a single enzyme but rather a collective term for a mixture of proteolytic (protein-digesting) enzymes and related non-proteolytic components derived from the pineapple plant (Ananas comosus (L.) Merr.), a member of the family Bromeliaceae. The bromelain enzyme complex includes primarily cysteine proteases — with stem bromelain (EC 3.4.22.32) and fruit bromelain (EC 3.4.22.33) as the main proteolytic components — alongside peroxidases, acid phosphatases, and other minor constituents.

Bromelain has a documented history of use in food technology (as a meat tenderizer), in the food industry, and as a nutritional supplement ingredient, and has been the subject of scientific research in nutritional, pharmacological, and clinical contexts for several decades.

Eating Pineapple vs. Concentrated Bromelain Preparations

An important distinction: consuming pineapple fruit as a food is fundamentally different from using a concentrated, standardized bromelain supplement ingredient. Fresh pineapple fruit does contain bromelain enzymes — which is why pineapple can tenderize meat and cause mild mouth tingling in some people — but the enzyme content per serving of fresh fruit is substantially lower than in concentrated bromelain preparations used in nutritional supplements, and enzyme activity in fresh fruit is affected by ripeness, variety, and storage conditions. Commercial bromelain ingredients are concentrated, standardized preparations produced primarily from pineapple stem, enabling defined enzyme activity per serving.

Why Pineapple Stem Is Used

Commercial bromelain used in nutritional supplement formulations is derived primarily from pineapple stem (the fibrous central core and stem of the pineapple plant) rather than from the edible fruit flesh. This is an important plant-part distinction:

  • Pineapple stem contains significantly higher concentrations of the bromelain enzyme complex than the fruit flesh, making it the commercially and economically viable source for concentrated bromelain ingredient production
  • Pineapple fruit flesh contains a related but lower-activity enzyme mixture (fruit bromelain), with substantially lower enzyme concentrations per gram than stem-derived preparations
  • By-product utilization: pineapple stem is generated in large quantities as an agricultural by-product of pineapple fruit processing, making stem-based bromelain extraction an efficient use of the plant

When a supplement label specifies “pineapple stem” or “pineapple stem bromelain,” it identifies the plant part source and distinguishes the ingredient from pineapple fruit powder. These are different ingredients with different enzyme activity profiles and should not be used interchangeably in evaluation or research comparison.

Proteolytic Enzyme Activity

“Proteolytic” refers to the ability to break down proteins through hydrolysis — the cleavage of peptide bonds that link amino acids together in protein chains. Proteolytic enzymes (also called proteases or peptidases) catalyze this process, breaking intact proteins into smaller peptides and ultimately into individual amino acids.

Bromelain’s proteolytic enzymes are classified as cysteine proteases, meaning they use a cysteine residue in the active site to facilitate protein cleavage. This class of enzyme activity is pH-dependent and has an activity optimum across a relatively broad pH range, which has implications for bromelain’s activity across different environments (including the gastrointestinal tract).

What Proteolytic Activity Means — and What It Doesn’t

The ability of bromelain to break down proteins in laboratory conditions — including in test-tube, in vitro, and food-technology contexts — is well established. However, demonstrating proteolytic activity in a controlled environment does not automatically translate to specific clinical effects in humans. In the gastrointestinal tract, bromelain must survive digestive conditions, reach relevant sites of action, and exert measurable physiological effects to produce a clinical outcome. Whether, and to what extent, orally consumed bromelain survives digestion and exerts systemic effects is a subject of ongoing research and is not uniformly established for all proposed applications.

Enzyme activity in a supplement is a quality and potency specification — not proof of a clinical effect.

Enzyme Potency: Activity Units vs. Milligrams

Enzyme ingredients present a unique evaluation challenge: unlike most nutritional compounds, where milligrams per serving is the primary potency metric, enzyme potency is more accurately described by enzyme activity units rather than mass alone.

Two bromelain preparations with identical milligram quantities per serving may have substantially different proteolytic activities if they have different activity levels per gram. Conversely, a lower-milligram preparation with a higher specific activity may deliver more proteolytic activity per serving than a higher-milligram preparation with lower specific activity.

Common Bromelain Activity Units

Several standardized activity unit systems are used for bromelain in the supplement industry and research literature:

  • GDU (Gelatin Digesting Units): measures the ability of the bromelain preparation to digest gelatin under standardized conditions; a common commercial specification
  • MCU (Milk Clotting Units): measures the ability to clot milk casein; used in some commercial specifications
  • FIP units: a European pharmacopoeial activity measurement standard
  • CDU (Casein Digesting Units): another proteolytic activity measurement based on casein digestion

These activity unit systems are not directly interchangeable, and conversions between them are approximate. When comparing bromelain products or research studies, the activity unit system used and the per-serving activity value are both relevant to accurate comparison.

AMLApure-specific note: For the exact bromelain amount, enzyme activity specification, and activity units used in the current Enterinex formulation(s), refer to the Supplement Facts panel on the individual product page. This page does not assert specific activity values that have not been verified from current product documentation.

Bromelain Research Overview

Bromelain has been studied across several research areas, with varying levels and types of evidence. The following represents an honest overview of the research landscape.

Biochemical and Mechanistic Research

Extensive biochemical research has characterized bromelain’s proteolytic enzyme activity, its structural properties, and its behavior in various pH environments. Laboratory research has also examined bromelain’s effects on various cell signaling molecules and inflammatory mediators in vitro. These findings are mechanistically informative but do not establish clinical outcomes in humans.

Animal Research

A substantial body of animal research has examined bromelain in various physiological models, including tissue injury models, inflammatory models, and gastrointestinal motility contexts. Animal research provides mechanistic context but has not been consistently replicated in human clinical settings.

Human Research Areas

Human clinical research on bromelain has examined several applications:

  • Post-surgical and post-traumatic tissue response: Some of the earlier and more studied human research on bromelain involved its use in post-surgical or post-traumatic tissue contexts, with older European clinical trials reporting effects on soft-tissue responses. These studies used various bromelain preparations and doses, and research quality is variable by contemporary standards.
  • Sinus and upper respiratory contexts: Bromelain has been studied in the context of sinus-related applications, and some human studies have examined bromelain supplementation in individuals with sinusitis-related symptoms. Evidence is limited and findings have been mixed.
  • Digestive enzyme supplementation: Bromelain is included in some multi-enzyme digestive supplement preparations. Research on multi-enzyme formulations in digestive contexts exists, though separating bromelain’s specific contribution within a multi-enzyme blend is methodologically challenging.
  • Osteoarthritis research: Some human studies and a systematic review have examined enzyme preparations containing bromelain (often in combination with other enzymes such as trypsin and rutin) in the context of osteoarthritis, with some findings suggesting effects on discomfort-related outcomes. These studies typically use combination enzyme preparations rather than bromelain alone, limiting conclusions about bromelain’s independent contribution.

What Human Research Shows

Bromelain has a more developed human clinical research base than many enzyme supplement ingredients, though the overall quality, consistency, and breadth of the evidence base warrants careful interpretation.

Tissue and Soft-Tissue Research

Among the more studied applications for bromelain in human research are post-surgical and post-traumatic soft-tissue contexts. A 2016 systematic review (Maurer, 2016; and earlier Braun et al. reviews) of bromelain in soft-tissue contexts noted evidence from multiple controlled trials suggesting potential benefit in relevant outcome measures. However, heterogeneity across studies, variable preparations, and variable methodological quality limit definitive conclusions.

Sinusitis Research

A randomized controlled trial (Gao et al., and earlier Braun et al. studies) examined bromelain supplementation in pediatric sinusitis patients, reporting some favorable outcomes compared to standard care. Evidence in adult populations is more limited. These findings do not establish bromelain as a medical treatment for sinusitis.

Combination Enzyme Research

Bromelain is a component of Wobenzym® and similar European oral enzyme preparations that have been examined in human osteoarthritis and inflammatory research contexts. A 2006 clinical study (Brien et al., QJM) compared an oral enzyme combination containing bromelain to diclofenac in knee osteoarthritis patients and reported comparable effects on some outcome measures. Interpreting these findings as evidence specifically for isolated bromelain is complicated by the multi-enzyme formulation used.

Honest Summary

Bromelain has a more developed human research background than many enzyme ingredients. The most studied contexts include soft-tissue and post-surgical applications, sinusitis, and combination enzyme preparations in musculoskeletal contexts. Evidence is promising in some areas but is generally based on older trials, variable preparations, and mixed quality. Bromelain’s mechanisms of action continue to be researched, and no current regulatory body has approved bromelain as a pharmaceutical treatment for any specific condition based on the existing evidence base.

Authoritative external resources: PubMed — bromelain human clinical research | NCCIH

Bromelain in Enterinex™

Bromelain (pineapple stem) is included as an enzyme component in all current AMLApure Enterinex formulations. Its inclusion reflects Enterinex’s multi-enzyme and botanical approach to digestive and systemic enzyme nutrition.

Products That Contain Bromelain

Bromelain / Pineapple Stem is currently used in all formulations within the Enterinex product line.

For the exact bromelain amount, enzyme activity specification, activity unit system, and per-serving details for each Enterinex formulation, refer to the Supplement Facts panel on the individual product page. AMLApure does not claim on this page that bromelain or Enterinex treats any disease, or that clinically proven synergy exists between bromelain and other Enterinex ingredients such as nattokinase, quercetin, piperine, or guava, unless supported by research on those exact formulation combinations.

Products That Do NOT Contain Bromelain

Bromelain and pineapple stem are not ingredients in:

  • AMLApure AMLA formulations
  • Glycanda™ Metabolic GLP-1 Support
  • AMLApure Nattokinase-only formulations
  • AMLApure Omega-3 formulation

For AMLApure’s broader formulation philosophy and ingredient standards, see The AMLApure Ingredient & Quality Pledge.

Bromelain vs. Eating Pineapple

A common question is whether eating pineapple provides the same benefit as taking a bromelain supplement. The answer requires attention to concentration, plant part, and preparation form.

Pineapple Fruit Flesh

Fresh pineapple fruit contains bromelain enzymes at naturally occurring concentrations in the fruit flesh. The enzymatic activity of fresh pineapple is sufficient to tenderize meat (a well-known culinary property) and can cause mild tingling or discomfort in the mouth due to proteolytic activity on oral tissue proteins. However, the enzyme activity per typical serving of fresh pineapple fruit is substantially lower than the activity delivered by a standardized concentrated bromelain supplement dose.

Pineapple Stem Extract

Commercial bromelain is produced primarily from pineapple stem, which contains significantly higher enzyme concentrations than the fruit flesh. The concentrated, standardized preparation used in supplement formulations delivers a defined enzyme activity per capsule or serving that cannot be replicated by eating fresh pineapple fruit in normal quantities.

Enzymatic Survival During Digestion

Whether orally consumed bromelain survives gastric digestion intact enough to exert systemic effects has been examined in research, with some studies demonstrating partial absorption of bromelain peptides. This question applies equally to bromelain from food and from supplements — but is more relevant in clinical contexts for concentrated preparations studied at defined activity doses.

Summary

Eating pineapple is nutritious and provides naturally occurring bromelain enzymes. It is not equivalent to consuming a standardized concentrated bromelain supplement ingredient, either in terms of enzyme activity delivered or in terms of comparability to clinical research conducted with defined bromelain preparations.

Quality & Formulation Considerations

Botanical Identity and Plant Part

Ananas comosus (L.) Merr. is the accepted scientific name for pineapple. Ingredient identity should specify the plant species and the plant part (stem vs. fruit). Stem-derived bromelain and fruit-derived preparations are different ingredients. Identity verification should use appropriate analytical methods.

Extraction and Concentration

Bromelain is typically extracted from pineapple stem through aqueous extraction, centrifugation, and precipitation or chromatographic purification steps. The extraction and purification process significantly influences the specific enzyme activity of the finished ingredient. A more highly purified preparation will generally have higher specific activity per gram than a crude extract.

Enzyme Activity Standardization

Quality bromelain ingredients are standardized to a defined enzyme activity level, expressed in GDU, MCU, FIP, or other applicable units per gram or per serving. This standardization is what enables consistent enzyme activity delivery across batches — which is particularly important for enzyme ingredients, where milligram weight alone is an insufficient potency descriptor. Responsible supplement formulation with bromelain should specify the activity unit system and per-serving activity value.

Enzyme Stability

Proteolytic enzymes including bromelain are subject to activity loss through heat, moisture, and prolonged storage. Proper manufacturing conditions — including temperature control during processing, appropriate encapsulation, and storage recommendations (cool, dry conditions) — are important for maintaining enzyme activity through the product’s shelf life. Finished product testing for enzyme activity at release and at end of shelf life supports quality assurance.

Third-Party Testing

Quality enzyme ingredient sourcing includes testing for botanical identity, enzyme activity (to confirm the specification), purity (heavy metals, pesticide residues, microbial contaminants), and allergen status. Third-party certificates of analysis are standard quality assurance expectations for responsibly sourced supplement ingredients.

Safety & Considerations

Please read this section carefully if you take prescription medications, have a known pineapple sensitivity, or are managing a medical condition.

General Tolerability

Bromelain from pineapple as a food is widely consumed without safety concerns in the general population. Concentrated bromelain supplement preparations deliver substantially higher enzyme activities than food consumption and may produce effects not observed with dietary pineapple intake.

Gastrointestinal Tolerance

Some individuals experience gastrointestinal effects with concentrated bromelain supplementation, including nausea, diarrhea, or digestive discomfort. These are typically dose-dependent. Individuals with a history of digestive sensitivity may wish to start at lower doses and assess tolerance before increasing.

Pineapple Sensitivity and Allergy

Individuals with known pineapple allergy or sensitivity should exercise caution with bromelain supplements derived from pineapple stem, as cross-reactive proteins may be present. Pineapple allergy, while not classified as a major food allergy under most regulatory frameworks, does occur. Individuals with pineapple or tropical fruit allergies should consult their healthcare provider before using bromelain supplements.

Anticoagulant and Antiplatelet Medications

Bromelain has been investigated in research examining effects on platelet aggregation and coagulation-related physiological markers. Laboratory and some clinical research has reported that bromelain may influence platelet aggregation under certain conditions. Individuals taking anticoagulant medications (such as warfarin, heparin) or antiplatelet medications (such as aspirin, clopidogrel) should discuss the use of concentrated bromelain supplements with their prescribing physician or pharmacist before use. The clinical significance of any interaction depends on the bromelain preparation, dose, and individual medication management context. This is not a claim that bromelain “thins the blood” as a therapeutic benefit — it is a safety consideration relevant to medication co-administration.

Pre-Surgery

Because of bromelain’s potential effects on platelet physiology and related processes, some guidelines recommend discussing concentrated enzyme supplement use with a surgical team before elective procedures. Individuals scheduled for surgery should inform their surgical team about all supplements they are taking, including bromelain-containing products.

Pregnancy and Breastfeeding

Pineapple as a food is consumed safely during pregnancy. Concentrated bromelain supplement preparations have not been adequately studied in pregnancy, and the safety of high-dose enzyme supplementation during pregnancy has not been established. Pregnant and breastfeeding individuals should consult their healthcare provider before using concentrated bromelain supplements.

Drug Interactions

Beyond anticoagulants, some pharmacological research has examined potential bromelain interactions with antibiotic absorption (some older studies reported altered tetracycline pharmacokinetics with bromelain co-administration). Individuals taking prescription medications should discuss bromelain supplement use with their pharmacist or physician.

Never modify or discontinue prescribed medical treatment in favor of a dietary supplement without explicit guidance from your prescribing physician.

This educational content is not a substitute for professional medical advice, diagnosis, or treatment.

Frequently Asked Questions

What is bromelain?

Bromelain is a collective term for a mixture of proteolytic (protein-digesting) enzymes and related constituents derived from the pineapple plant (Ananas comosus). It is not a single enzyme but an enzyme complex, with stem bromelain and fruit bromelain as the primary proteolytic components. Bromelain has been used in food technology as a protein-digesting ingredient and has been the subject of nutritional and clinical research for several decades.

Where does bromelain come from?

Bromelain is derived from the pineapple plant (Ananas comosus), which is native to South America and now cultivated across tropical regions worldwide. Commercial bromelain used in nutritional supplements is derived primarily from the pineapple stem (the fibrous core and stalk), which contains significantly higher enzyme concentrations than the edible fruit flesh. Pineapple stem is produced in large quantities as a by-product of pineapple fruit processing, making it the economically practical source for commercial bromelain production.

Why is bromelain extracted from pineapple stems?

Pineapple stem contains substantially higher concentrations of the bromelain enzyme complex than the edible fruit flesh. Stem-derived bromelain has higher specific enzyme activity per gram, making it a more concentrated and commercially viable source for supplement-grade preparations. Pineapple stem is also generated as a processing by-product, supporting efficient use of the plant material. Ingredient labels specifying “pineapple stem” or “pineapple stem bromelain” identify this plant-part distinction.

What is a proteolytic enzyme?

A proteolytic enzyme (also called a protease or peptidase) is an enzyme that breaks down proteins by cleaving the peptide bonds that link amino acids together. This process — protein hydrolysis — converts intact proteins into smaller peptides and ultimately into individual amino acids. Bromelain’s proteolytic enzymes are classified as cysteine proteases and are active across a relatively broad pH range. Proteolytic activity in a controlled environment does not automatically translate to specific clinical effects when the enzyme is consumed orally.

Is bromelain the same as eating pineapple?

No. Fresh pineapple fruit contains naturally occurring bromelain enzymes, but at substantially lower activity levels than concentrated supplement-grade preparations. Commercial bromelain supplements use pineapple stem extract — which has much higher enzyme activity than fruit flesh — and are concentrated and standardized to deliver a defined enzyme activity per serving. Eating pineapple is nutritious but is not equivalent to consuming a standardized bromelain supplement preparation, either in terms of enzyme activity delivered or in terms of comparability to research conducted with defined bromelain preparations.

How is bromelain potency measured?

Bromelain potency is most accurately measured by enzyme activity rather than milligram weight alone. Common bromelain activity unit systems include GDU (Gelatin Digesting Units), MCU (Milk Clotting Units), FIP units (European pharmacopoeial standard), and CDU (Casein Digesting Units). Different unit systems measure different aspects of proteolytic activity and are not directly interchangeable. When evaluating a bromelain ingredient’s potency, the activity unit system used and the per-serving activity value together provide a more meaningful specification than milligrams alone.

Are enzyme activity units different from milligrams?

Yes — this is an important distinction for enzyme ingredients. Milligrams measure mass (how much of the ingredient is present by weight). Enzyme activity units measure functional potency (how much proteolytic work the enzyme can perform under standardized conditions). Two bromelain preparations with the same milligram quantity may have substantially different enzyme activities if their specific activities per gram differ. For enzyme ingredients, activity units are the more relevant potency descriptor for evaluating whether a serving delivers a meaningful amount of functional enzyme.

What does human research on bromelain show?

Bromelain has a more developed human research base than many enzyme ingredients. The most studied human applications include post-surgical and post-traumatic soft-tissue contexts, sinusitis-related outcomes, and combination enzyme preparations in musculoskeletal research. Some controlled human trials report favorable outcomes in relevant contexts. However, the evidence base is generally based on older trials, variable preparations and doses, and mixed methodological quality. Bromelain is not approved as a pharmaceutical treatment for any specific condition in major regulatory jurisdictions based on current evidence.

Why is bromelain included in Enterinex?

Bromelain is included as a proteolytic enzyme component within the broader Enterinex enzyme and botanical formulation strategy. Its inclusion reflects the role of plant-derived proteolytic enzymes as a component of Enterinex’s multi-enzyme nutritional approach. AMLApure does not claim that bromelain or Enterinex treats any disease, or that proven clinical synergy exists between bromelain and other Enterinex ingredients unless supported by research on those exact combinations.

Which AMLApure products contain bromelain?

Bromelain / Pineapple Stem is used in the Enterinex product line (all current Enterinex formulations). It is not an ingredient in AMLApure AMLA formulations, Glycanda™, AMLApure Nattokinase-only formulations, or the AMLApure Omega-3 formulation. For exact bromelain amounts, enzyme activity specifications, and activity units, refer to the Supplement Facts panel on the individual Enterinex product page.

References & Further Reading

  • Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001;58(9):1234–1245. PubMed
  • Brien S, et al. Bromelain as a treatment for osteoarthritis: a review of clinical studies. Evid Based Complement Alternat Med. 2004;1(3):251–257. PubMed
  • Brien S, et al. Bromelain as an adjunctive treatment for moderate-to-severe osteoarthritis of the knee: a randomized placebo-controlled pilot study. QJM. 2006;99(12):841–850. PubMed
  • Braun JM, et al. Therapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in Germany. In Vivo. 2005;19(2):417–421. PubMed
  • Rathnavelu V, et al. Potential role of bromelain in clinical and therapeutic applications. Biomed Rep. 2016;5(3):283–288. PubMed
  • Pavan R, et al. Properties and therapeutic application of bromelain: a review. Biotechnol Res Int. 2012;2012:976203. PubMed
  • PubMed: Bromelain human clinical research

This page is part of the AMLApure Ingredient Science Library. Content is educational and does not constitute medical advice. These statements have not been evaluated by the FDA. AMLApure products are not intended to diagnose, treat, cure, or prevent any disease.